bluebird bio (BLUE) Misses Q1 EPS by 15c

bluebird bio (NASDAQ: BLUE) reported Q1 EPS of ($0.76), $0.15 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $6.3 million versus the consensus estimate of $6.2 million.

For earnings history and earnings-related data on bluebird bio (BLUE) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Linde (LIN) PT Lowered to $563 at Bernstein SocGen Group
• Oracle’s Ellison cancels plan to sell up to 50 mln shares